Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Akoya Biosciences, Inc.
- LUMOS PHARMA, INC.
Updated Jul 16, 2026
Raffin Thomas A. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-08 | AKYA | Akoya Biosciences, Inc. | J — Other acquisition / disposition | 15.94M | — | |
| 2025-07-08 | AKYA | Akoya Biosciences, Inc. | J — Other acquisition / disposition | 1.74M | — | |
| 2025-07-08 | AKYA | Akoya Biosciences, Inc. | J — Other acquisition / disposition | 234.6K | — | |
| 2024-12-13 | (LUMO) | LUMOS PHARMA, INC. | D — Derivative transaction | 9.4K | — |
Raffin Thomas A. is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Raffin Thomas A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.